title: Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma.
abstract: BACKGROUND
  We recently demonstrated that T lymphocytes in bronchoalveolar lavage (BAL) fluid from atopic asthmatic patients were activated and expressed increased cytokine messenger ribonucleic acid (mRNA) for "TH2-type" cytokines, particularly IL-4 and IL-5, when compared with those in normal control subjects. This pattern of cytokines may determine the nature of the cellular infiltrate in the bronchial mucosa in asthma and hence the bronchial hyperresponsive (BHR) and symptoms that characterize this condition.
  
  
  METHODS
  To examine the association between these cytokines and clinical measures of asthma severity we have extended our studies of BAL cells from subjects with atopic asthma. Numbers of BAL cells with positive in situ hybridization signals for IL-2, IL-3, IL-4, IL-5, granulocyte macrophage colony-stimulating factor (GM-CSF), and interferon-gamma were counted on cytocentrifuge preparations. Results were compared between patients with symptomatic (n = 19) and asymptomatic asthma (n = 10), and associations were sought with airway methacholine responsiveness, resting airway caliber, and asthma symptom scores.
  
  
  RESULTS
  There were increased proportions of cells positive for IL-3 (p < 0.05), IL-4 (p < 0.005), IL-5 (p < 0.005), and GM-CSF (p < 0.005) mRNA in BAL fluid from patients with symptomatic asthma when compared with that from subjects free of symptoms, but no difference between the groups in numbers of cells expressing IL-2 and interferon-gamma mRNA. There were significant associations among numbers of cells expressing mRNA for IL-4, IL-5, and GM-CSF, and airflow restriction, BHR, and Aas asthma score.
  
  
  CONCLUSIONS
  These findings support the hypothesis that cytokines contribute to airway events that determine asthma symptoms and BHR.
authors.affiliation: Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, United Kingdom.
authors.forename: D S
authors.initials: DS
authors.lastname: Robinson
authors.forename: S
authors.initials: S
authors.lastname: Ying
authors.forename: A M
authors.initials: AM
authors.lastname: Bentley
authors.forename: Q
authors.initials: Q
authors.lastname: Meng
authors.forename: J
authors.initials: J
authors.lastname: North
authors.forename: S R
authors.initials: SR
authors.lastname: Durham
authors.forename: A B
authors.initials: AB
authors.lastname: Kay
authors.forename: Q
authors.initials: Q
authors.lastname: Hamid
mesh_terms: D000328:Adult; D001249:Asthma / Q000276:immunology* / Q000503:physiopathology; D001985:Bronchial Provocation Tests; D001992:Bronchoalveolar Lavage Fluid / Q000276:immunology*; D016207:Cytokines / Q000235:genetics*; D005260:Female; D006801:Humans; D017403:In Situ Hybridization; D008297:Male; D016210:Methacholine Chloride; D012333:RNA, Messenger / Q000378:metabolism*
chemical_list: D016207:Cytokines; D012333:RNA, Messenger; D016210:Methacholine Chloride